Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0U7VU
|
|||
| Former ID |
DNCL003643
|
|||
| Drug Name |
MLN0264
|
|||
| Indication | Gastrointestinal cancer [ICD-11: 2C11] | Phase 2 | [1] | |
| Company |
Millenium; The Takeda oncology company
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Guanylyl cyclase C (GUCY2C) | Target Info | Modulator | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT02202759) A Study of MLN0264 in Patients With Cancer of the Stomach or Gastroesophageal Junction. U.S. National Institutes of Health. | |||
| REF 2 | J Clin Oncol 31, 2013 (suppl; abstr TPS3646). | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.